Hologic Announces Voluntary Recall Of Implantable BioZorb Marker Devices
MARLBOROUGH, Mass. — Hologic Inc., facing litigation from cancer patients who allege that an implanted radiographic marker used to mark soft tissue sites during cancer treatment was defective and caused injuries,...To view the full article, register now.
Already a subscriber? Click here to view full article